Skip to content

Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.

Featured In Digestive Health

Ashwin Ananthakrishnan, MD, discusses the AGA guideline's key recommendations for managing Crohn's disease and the evolving role of biomarkers in these treatments.

Featured In Oncology

Researchers at Massachusetts General Hospital won a Breakthrough Award to enhance personalized approaches to immunotherapy for metastatic melanoma.

Featured In Otolaryngology

Yong Tao, PhD, Veronica Lamas, PhD, and Zheng-Yi Chen, DPhil, have extended their previous murine research to show CRISPR-associated protein 9 (Cas9)-based genome editing can treat hearing loss associated with monogenic mutations in outer hair cell genes and digenic mutations affecting both inner and outer hair cells.

Featured In Cardiovascular

A Massachusetts General Hospital cardiology fellow launched You Belong in Cardiology to build a pipeline for women and underrepresented minorities in cardiology.

Featured In Neuroscience

A new online forum educates healthcare providers about restless leg syndrome augmentation, risks of treatment with ropinirole or pramipexole, and treatment alternatives.

The Latest Ophthalmology Advances

Inês Laíns, MD, PhD, and colleagues summarize the robust scientific evidence that compassion can measurably improve patient outcomes and the well-being of healthcare providers. They outline strategies for measuring compassion, and to train and cultivate compassionate care.

Reza Dana, MD, MSc, MPH; Jia Yin, MD, PhD, MPH; Ula V. Jurkunas, MD; and colleagues have discovered a critical role for neuropeptides in maintenance of corneal endothelial cells and potential therapeutic applications for α-melanocyte–stimulating hormone after corneal injury or intraocular surgery.

Contributing Physicians

Frederick A. Jakobiec Director of the David Glendenning Cogan Laboratory of Ophthalmic Pathology, Fellowship Director, Ophthalmic Pathology, Mass Eye and Ear, Assistant Professor of Ophthalmology, Harvard Medical School

Anna Stagner, MD, Profile Photo

Director, Cornea Service, Associate Chief for Academic Programs, Mass Eye and Ear, Claes H. Dohlman Professor of Ophthalmology, Harvard Medical School

Reza Dana, MD, MSc, MPH, Profile

Advances Specialties


Melissa S. Putman, MD, and colleagues correlated findings on continuous glucose monitoring with a decline in body weight and a decline in body mass index over one year in adults with cystic fibrosis. Their data also suggest advanced glycation end products may represent a useful marker in this population.


Michael C. Dean, BA, Scott D. Martin, MD, and colleagues are the first to identify chondrolabral junction breakdown, observed intraoperatively, as a risk factor for eventual conversion to total hip arthroplasty after hip arthroscopy for symptomatic labral tears secondary to femoroacetabular impingement.

Rheumatology, Allergy and Immunology

A 49-year-old male presented to Massachusetts General Hospital, found to have new heart failure with a reduced ejection fraction and pericardial effusion. Testing revealed elevated cytomegalovirus (CMV) viral load, so the Pathways Service investigated how a previously immunocompetent patient developed CMV reactivation.

Education & Training Opportunities

May 10, 2024

The Midlife Women's Health 2024 course is led by a multidisciplinary group of experts from Massachusetts General Hospital who will present on the evaluation and management of gynecologic cancers, cardiovascular health, menopausal hormone therapy, ADHD, sexuality after cancer, and more to assist clinicians in caring for their midlife patients. The entire program will be available to registrants for 30 days after the event, with CME credit provided only to those who log in on the day of the conference.

May 4-8, 2024

Considered the premier psychiatry event of the year, the American Psychiatric Association's 2024 Annual Meeting takes place May 4–8 in New York City. The Department of Psychiatry at Massachusetts General Hospital will present their latest research at this year's event.